XML 53 R42.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
The following table summarizes restricted stock activity for the years ended December 31, 2019, 2018, and 2017:
 
Restricted Stock
 
Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Outstanding at December 31, 2016
2,433,915

 
4.48

Granted
799,165

 
8.78

Vested
(1,023,708
)
 
5.14

Canceled/Forfeited
(53,527
)
 
5.90

Outstanding at December 31, 2017
2,155,845

 
5.72

Granted
1,000,690

 
7.63

Vested
(1,277,076
)
 
5.30

Canceled/Forfeited
(337,811
)
 
6.51

Outstanding at December 31, 2018
1,541,648

 
7.14

Granted
1,586,590

 
4.90

Vested
(797,025
)
 
6.36

Canceled/Forfeited
(146,538
)
 
5.70

Outstanding at December 31, 2019
2,184,675

 
$
5.89


Summary of Grants Awarded
The following table summarizes stock option and SAR activity for the years ended December 31, 2019, 2018, and 2017:
 
Stock Options
 
SARs
 
Shares
 
Weighted
Average
Exercise
Price
 
Shares
 
Weighted
Average
Exercise
Price
Outstanding at December 31, 2016
656,611

 
10.76

 
42,152

 
14.14

Granted
14,820

 
7.60

 

 

Exercised
(26,966
)
 
3.28

 

 

Canceled/forfeited
(27,019
)
 
21.88

 

 

Outstanding at December 31, 2017
617,446

 
10.53

 
42,152

 
14.14

Granted
14,310

 
7.91

 

 

Exercised
(159,069
)
 
3.35

 

 

Canceled/forfeited
(153,601
)
 
11.48

 

 

Outstanding at December 31, 2018
319,086

 
13.53

 
42,152

 
14.14

Exercised
(11,055
)
 
5.57

 

 

Canceled/forfeited
(11,519
)
 
9.31

 

 

Expired
(4,733
)
 
10.00

 
(9,870
)
 
10.00

Outstanding at December 31, 2019
291,779

 
14.05

 
32,282

 
15.40


Share-based Compensation, Performance Shares Award Outstanding Activity [Table Text Block]
The following table summarizes performance shares activity for the years ended December 31, 2019, 2018, and 2017:
 
Performance Shares
 
Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Outstanding at December 31, 2016
2,372,632

 
4.53

Granted
316,213

 
11.58

Vested
(66,696
)
 
14.18

Canceled/Forfeited
(253,868
)
 
11.56

Outstanding at December 31, 2017
2,368,281

 
4.44

Granted (1)
869,421

 
7.41

Vested
(1,086,058
)
 
6.83

Canceled/Forfeited
(613,329
)
 
5.41

Outstanding at December 31, 2018
1,538,315

 
4.05

Granted (2)
946,000

 
4.71

Vested
(969,903
)
 
1.77

Canceled/Forfeited (2)
(300,267
)
 
1.84

Outstanding at December 31, 2019
1,214,145

 
6.93


(1) Includes 461,242 additional shares granted in connection with the vesting of the 2015 award in 2018 due to above-target performance in accordance with the terms of the awards.
(2) Includes 207,264 additional shares granted and 300,267 shares cancelled in connection with the vesting of the 2016 award in 2019 due to above-target and below target performance, respectively, in accordance with the terms of the award.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The following table sets forth the weighted average fair value of stock options and the assumptions used to estimate the fair value of the stock options using the Black-Scholes option valuation model:
 
2019
 
2018
 
2017
Weighted average fair value of stock options granted
$

 
$
4.09

 
$
3.91

Volatility

 
66.86
%
 
67.07
%
Expected life in years
0

 
4.00

 
4.00

Risk-free interest rate

 
2.07
%
 
1.69
%
Dividend yield

 

 


Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]
The following table summarizes outstanding stock options as of December 31, 2019.
Range of
Exercise Price
Number
Outstanding
 
Weighted Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
Aggregate Intrinsic Value (in thousands)
$ 0.00-$10.00
181,188

 
$
7.64

 
5.3
 

$10.00-$20.00
14,634

 
$
16.28

 
2.9
 

$20.00-$30.00
95,957

 
$
25.83

 
2.3
 

Outstanding
291,779

 
$
14.05

 
4.2
 
$

Vested and expected to vest
290,892

 
$
14.07

 
4.2
 
$

Exercisable
277,299

 
$
14.38

 
4.0
 
$